Johnson & Johnson JNJ MEDTECH — Additions to Property, Plant & Equipment
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Johnson & Johnson in its filing.
Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.
The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →
Ask your AI about Johnson & Johnson's medtech — additions to property, plant & equipment.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Johnson & Johnson's MEDTECH — additions to property, plant & equipment?
- Johnson & Johnson (JNJ) reported MEDTECH — additions to property, plant & equipment of $509M in Q1 2026.
- How has Johnson & Johnson's MEDTECH — additions to property, plant & equipment changed year-over-year?
- Johnson & Johnson's MEDTECH — additions to property, plant & equipment increased by 6.0% year-over-year, from $480M to $509M.
- What is the long-term trend for Johnson & Johnson's MEDTECH — additions to property, plant & equipment?
- Over 4 years (2021 to 2025), Johnson & Johnson's MEDTECH — additions to property, plant & equipment has grown at a 6.7% compound annual growth rate (CAGR), from $1.93B to $2.5B.
- What does MEDTECH — additions to property, plant & equipment mean?
- This metric measures the capital expenditure (CapEx) invested in physical infrastructure, machinery, and facilities specifically for the medical technology segment. It reflects the company's commitment to expanding production capacity or upgrading technology. High levels of investment are typically associated with growth phases or modernization efforts.